Cargando…

Functional validation of a human GLUD2 variant in a murine model of Parkinson’s disease

Parkinson’s disease (PD) is a common neurodegenerative disease characterized by Lewy body formation and progressive dopaminergic neuron death in the substantia nigra (SN). Genetic susceptibility is a strong risk factor for PD. Previously, a rare gain-of-function variant of GLUD2 glutamate dehydrogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wenlong, Gong, Junwei, Ding, Liuyan, Zhang, Zhiling, Pan, Xiaowen, Chen, Xiang, Guo, Wenyuan, Zhang, Xiaokang, Yang, Xinling, Peng, Guoyou, Lin, Yuwan, Gao, Feng, Li, Yuanquan, Zhu, Xiaoqin, Xuan, Aiguo, Wang, Shu, Sun, Xiangdong, Zhang, Yunlong, Xu, Pingyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582183/ https://www.ncbi.nlm.nih.gov/pubmed/33093440 http://dx.doi.org/10.1038/s41419-020-03043-2

Ejemplares similares

CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes
por: Zhang, Wenlong, et al.
Publicado: (2020)

Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson’s Disease Model
por: Huang, Shuxuan, et al.
Publicado: (2021)

Trojan Horse Delivery of 4,4′‐Dimethoxychalcone for Parkinsonian Neuroprotection
por: Zhang, Wenlong, et al.
Publicado: (2021)

Bone-Derived Factors as Potential Biomarkers for Parkinson’s Disease
por: Lin, Yuwan, et al.
Publicado: (2021)

Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson’s Disease
por: Mo, Mingshu, et al.
Publicado: (2021)

CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in in vitro and in vivo models of Parkinson’s disease
por: Chen, Xiang, et al.
Publicado: (2023)

Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease
por: Qiu, Jiewen, et al.
Publicado: (2023)

Cntnap4 partial deficiency exacerbates α-synuclein pathology through astrocyte–microglia C3-C3aR pathway
por: Zhang, Wenlong, et al.
Publicado: (2023)

Modified Huang-Lian-Jie-Du Decoction Ameliorates Aβ Synaptotoxicity in a Murine Model of Alzheimer's Disease
por: Liu, Yan, et al.
Publicado: (2019)

Association of LAG3 genetic variation with an increased risk of PD in Chinese female population
por: Guo, Wenyuan, et al.
Publicado: (2019)

Lactobacillus reuteri normalizes altered fear memory in male Cntnap4 knockout mice
por: Zhang, Wenlong, et al.
Publicado: (2022)

Reduced regional activity and functional connectivity within sensorimotor network in Parkinson’s patients with restless legs syndrome
por: Li, Zhe, et al.
Publicado: (2019)

Biomimetic Remodeling of Microglial Riboflavin Metabolism Ameliorates Cognitive Impairment by Modulating Neuroinflammation
por: Zhang, Mengran, et al.
Publicado: (2023)

Involvement of GluD2 in Fear-Conditioned Bradycardia in Mice
por: Kotajima-Murakami, Hiroko, et al.
Publicado: (2016)

Mosaic GLUD1 Mutations Associated with Hyperinsulinism Hyperammonemia Syndrome
por: Boodhansingh, Kara E., et al.
Publicado: (2022)

Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's Disease
por: Zhang, Yunlong, et al.
Publicado: (2016)

Differential levels of glutamate dehydrogenase 1 (GLUD1) in Balb/c and C57BL/6 mice and the effects of overexpression of the Glud1 gene on glutamate release in striatum
por: Hascup, Kevin N, et al.
Publicado: (2011)

CHCHD2 maintains mitochondrial contact site and cristae organizing system stability and protects against mitochondrial dysfunction in an experimental model of Parkinson's disease
por: Lu, Lin, et al.
Publicado: (2022)

Lipid Metabolism Disorder in Cerebrospinal Fluid Related to Parkinson’s Disease
por: Qiu, Jiewen, et al.
Publicado: (2023)

GluD1, linked to schizophrenia, controls the burst firing of dopamine neurons
por: Benamer, N, et al.
Publicado: (2018)

Mitochondrial enzyme GLUD2 plays a critical role in glioblastoma progression
por: Franceschi, Sara, et al.
Publicado: (2018)

STUB1-mediated ubiquitination regulates the stability of GLUD1 in lung adenocarcinoma
por: Hu, Qifan, et al.
Publicado: (2023)

Potentiation of neuronal activity by tonic GluD1 current in brain slices
por: Copeland, Daniel S, et al.
Publicado: (2023)

A Novel Hydrogen Sulfide Donor Reduces Pilocarpine-Induced Status Epilepticus and Regulates Microglial Inflammatory Profile
por: Liu, Zhongrui, et al.
Publicado: (2021)

Microglial targeted therapy relieves cognitive impairment caused by Cntnap4 deficiency
por: Zhang, Wenlong, et al.
Publicado: (2023)

Hyperinsulinism–hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype–phenotype correlations
por: Kapoor, Ritika R, et al.
Publicado: (2009)

Characterization of a new rice glutelin gene GluD-1 expressed in the starchy endosperm
por: Kawakatsu, Taiji, et al.
Publicado: (2008)

Spectrum of neuro-developmental disorders in children with congenital hyperinsulinism due to activating mutations in GLUD1
por: Aftab, Sommayya, et al.
Publicado: (2022)

Disruption of cerebellar microzonal organization in GluD2 (GluRδ2) knockout mouse
por: Hashizume, Miki, et al.
Publicado: (2013)

Probing the ionotropic activity of glutamate GluD2 receptor in HEK cells with genetically-engineered photopharmacology
por: Lemoine, Damien, et al.
Publicado: (2020)

Oncogenic circTICRR suppresses autophagy via binding to HuR protein and stabilizing GLUD1 mRNA in cervical cancer
por: Zhu, Tingjia, et al.
Publicado: (2022)

Cryo-EM Structures of the Ionotropic Glutamate Receptor GluD1 Reveal a Non-Swapped Architecture
por: Burada, Ananth Prasad, et al.
Publicado: (2020)

Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease
por: Zhang, Yunlong, et al.
Publicado: (2017)

The low binding affinity of D-serine at the ionotropic glutamate receptor GluD2 can be attributed to the hinge region
por: Tapken, Daniel, et al.
Publicado: (2017)

Hyperinsulinism associated with GLUD1 mutation: allosteric regulation and functional characterization of p.G446V glutamate dehydrogenase
por: Luczkowska, Karolina, et al.
Publicado: (2020)

GLUD1 suppresses renal tumorigenesis and development via inhibiting PI3K/Akt/mTOR pathway
por: Wang, Lei, et al.
Publicado: (2022)

Gene expression patterns in the hippocampus during the development and aging of Glud1 (Glutamate Dehydrogenase 1) transgenic and wild type mice
por: Wang, Xinkun, et al.
Publicado: (2014)

Correction to: Hyperinsulinism associated with GLUD1 mutation: allosteric regulation and functional characterization of p.G446V glutamate dehydrogenase
por: Luczkowska, Karolina, et al.
Publicado: (2021)

The biomarkers of immune dysregulation and inflammation response in Parkinson disease
por: Chen, Li, et al.
Publicado: (2016)

A novel mutation in GLUD1 causing hyperinsulinism-hyperammonemia in a patient with high density of homozygosity on microarray: a case report
por: Odom, John, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5trip5b3jv6gqgc9cdgtac2kv6